Cite
HARVARD Citation
Nyirjesy, P. et al. (2022). Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Clinical infectious diseases. pp. 2129-2135. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nyirjesy, P. et al. (2022). Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Clinical infectious diseases. pp. 2129-2135. [Online].